计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| H114599-10mg |
10mg |
现货 ![]() |
| |
| H114599-50mg |
现货 ![]() |
| ||
| H114599-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | 2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid | Haloxyfop Acid | HY-B1856 | C04871 | 2-(4-(3-chloro-5-(trifluoromethyl)pyridin-2-yloxy)phenoxy)propanoic acid | (+/-)-Haloxyfop | Haloxyfop [ANSI:BSI:ISO] | SY107474 | 2-[4-[3-ch |
|---|---|
| 规格或纯度 | 分析标准品 |
| 英文名称 | Haloxyfop |
| 运输条件 | 常规运输 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IUPAC Name | 2-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]propanoic acid |
| INCHI | InChI=1S/C15H11ClF3NO4/c1-8(14(21)22)23-10-2-4-11(5-3-10)24-13-12(16)6-9(7-20-13)15(17,18)19/h2-8H,1H3,(H,21,22) |
| InChi Key | GOCUAJYOYBLQRH-UHFFFAOYSA-N |
| Canonical SMILES | CC(C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl |
| Isomeric SMILES | CC(C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl |
| PubChem CID | 50895 |
| 分子量 | 361.7 |
| 密度 | 1.442 |
|---|---|
| 分子量 | 361.700 g/mol |
| XLogP3 | 4.200 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 361.033 Da |
| 单同位素质量Monoisotopic Mass | 361.033 Da |
| 拓扑极表面积Topological Polar Surface Area | 68.700 Ų |
| 重原子数Heavy Atom Count | 24 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 429.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 1 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS05, GHS07 |
|---|---|
| 信号词 | Danger |
| 危险声明 |
H412: 对水生生物有害并具有长期持续影响 H302: 吞食有害 H318: 造成严重的眼睛损伤 |
| 预防措施声明 |
P273: 避免释放到环境中。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P330: 漱口 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P305+P354+P338: 如果进入眼睛:立即用水冲洗几分钟。取下隐形眼镜(如果有的话),并且操作简单。继续冲洗。 P317: 寻求紧急医疗救助。 |
| Purity(HPLC) | 98-100(%) |
|---|---|
| Infrared spectrum | Conforms to Structure |
| Proton NMR spectrum | Conforms to Structure |
| 1. Yuanjing Lin, Jialiang Guo, Hang Lin, Jincai Wang, Govert W. Somsen, Jacques Crommen, Zhengjin Jiang. (2017) Effect of fabrication strategy on the enantioseparation performance of β-cyclodextrin-functionalized polymethacrylate monoliths: A comparative evaluation. JOURNAL OF SEPARATION SCIENCE, 40 (19): (3754-3762). [PMID:28749038] [10.1002/jssc.201700424] |
| 2. Jialiang Guo, Yuan Xiao, Yuanjing Lin, Jacques Crommen, Zhengjin Jiang. (2016) Effect of the crosslinker type on the enantioseparation performance of β-cyclodextrin functionalized monoliths prepared by the one-pot approach. JOURNAL OF CHROMATOGRAPHY A, 1467 (288). [PMID:27268520] [10.1016/j.chroma.2016.05.078] |
| 1. Yuanjing Lin, Jialiang Guo, Hang Lin, Jincai Wang, Govert W. Somsen, Jacques Crommen, Zhengjin Jiang. (2017) Effect of fabrication strategy on the enantioseparation performance of β-cyclodextrin-functionalized polymethacrylate monoliths: A comparative evaluation. JOURNAL OF SEPARATION SCIENCE, 40 (19): (3754-3762). [PMID:28749038] [10.1002/jssc.201700424] |
| 2. Jialiang Guo, Yuan Xiao, Yuanjing Lin, Jacques Crommen, Zhengjin Jiang. (2016) Effect of the crosslinker type on the enantioseparation performance of β-cyclodextrin functionalized monoliths prepared by the one-pot approach. JOURNAL OF CHROMATOGRAPHY A, 1467 (288). [PMID:27268520] [10.1016/j.chroma.2016.05.078] |